SHAYLO REYES: Open Payments
NPI 1700372323 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 21 payments from 8 companies in 2025. Trend: 2023 $938 · 2024 $1,051 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $248 |
| ViiV Healthcare Company | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $59 |
| Novo Nordisk Inc | 2 | $37 |
| Dexcom, Inc. | 1 | $36 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Indivior Inc. | 1 | $19 |
Products named: Descovy, Kerendia, DOVATO, Ozempic, Dexcom G6 Transmitter, PIFELTRO, RUKOBIA, ACCRUFER.
Industry payments across SC — which companies pay providers there.
